MELINDA ZAHNER: Open Payments
NPI 1538679121 · CONCORD TWP, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,018 in 108 payments from 20 companies in 2025. Trend: 2023 $2,086 · 2024 $2,431 · 2025 $2,018
Food & beverage: $2,018
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $344 |
| Novo Nordisk Inc | 13 | $221 |
| Esperion Therapeutics, Inc. | 9 | $174 |
| Amgen Inc. | 10 | $155 |
| E.R. Squibb & Sons, L.L.C. | 7 | $121 |
| Alnylam Pharmaceuticals Inc. | 4 | $114 |
| Boston Scientific Corporation | 4 | $113 |
| AstraZeneca Pharmaceuticals LP | 6 | $106 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $101 |
| UCB, Inc. | 3 | $91 |
Products named: LEQVIO, NEXLETOL, Wegovy, REPATHA, ELIQUIS, ONPATTRO, JARDIANCE, General - Therapies.
Industry payments across OH — which companies pay providers there.
